Market Tracker

04/24 6:02pm ET

EPIRUS Biopharmaceuticals Inc (NASDAQ:EPRS)

8.67
Delayed Data
As of Apr 24
 -0.10 / -1.14%
Today’s Change
3.78
Today|||52-Week Range
16.90
+52.91%
Year-to-Date
No recent news for EPIRUS Biopharmaceuticals Inc.

Today’s Trading

Previous close8.77
Today’s open9.30
Day’s range8.53 - 9.30
Volume160,668
Average volume (3 months)341,426
Market cap$206.2M
Dividend yield--
Data as of 4:00pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+59.46%
Earnings growth (this year)+75.70%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.97%
P/E ratioNM
Price/Sales8,705.73
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RPRXRepros Therapeutics ...-0.06-0.71%
ACRXAcelRx Pharmaceutica...-0.16-3.38%
XENEXenon Pharmaceutical...-0.10-0.68%
AFMDAffimed NV+3.47+42.06%
Data as of 4:00pm ET, 04/24/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$4.0K
Annual profit (last year)-$41.8M
Net profit margin-1,046,100.00%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Amit D. Munshi
Chief Financial Officer &
Treasurer
Thomas A. Shea
Corporate headquarters
Boston, Massachusetts

Forecasts